INR 1350.95
(-1.41%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 2.75 Billion | 1.07 Billion | 1.79 Billion | 2.24 Billion | 1.8 Billion | 3.43 Billion |
Net Income | 3.17 Billion | -118.2 Million | -403.7 Million | 494.8 Million | 241.1 Million | 1.41 Billion |
Depreciation & Amortization | 467 Million | 491.9 Million | 879 Million | 1.2 Billion | 1.34 Billion | 1.42 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -760.9 Million | -280.6 Million | 918.7 Million | 37 Million | 428.7 Million | 551.6 Million |
Other non-cash items | 1.01 Billion | 977.7 Million | 398.4 Million | 512.4 Million | -202.2 Million | 37 Million |
Investing Cash Flow | -700.6 Million | -24.8 Million | -140.6 Million | -622 Million | 49.5 Million | -668.1 Million |
Investments in PPE | -685.9 Million | -174.9 Million | -403.8 Million | -409.7 Million | -237.3 Million | -779.9 Million |
Acquisitions | 1.2 Million | -100 Thousand | -100 Thousand | -200 Thousand | -100 Thousand | -200 Thousand |
Investment purchases | -15.9 Million | -100 Thousand | -100 Thousand | -277.3 Million | -100 Thousand | -131 Million |
Sales/Maturities of investments | - | 122.5 Million | 235.6 Million | 30 Million | 144.9 Million | 182.5 Million |
Other Investing Activities | 7.2 Million | 27.8 Million | 27.8 Million | 35.2 Million | 142.1 Million | 60.5 Million |
Financing Cash Flow | -2.16 Billion | -1.02 Billion | -1.89 Billion | -1.04 Billion | -2.02 Billion | -2.62 Billion |
Debt repayment | -2.15 Billion | -997.3 Million | -1.47 Billion | -615.3 Million | -1.79 Billion | -2.29 Billion |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -781 Million | -32.5 Million | -418.4 Million | -429.7 Million | -236.4 Million | -321.7 Million |
Accounts receivables | -244.5 Million | -399 Million | 1.1 Billion | 372.8 Million | 304.4 Million | 452.7 Million |
Accounts payables | 507.2 Million | -106 Million | -362.9 Million | -265.5 Million | -269.5 Million | 130 Million |
Inventory | -470.4 Million | -242.6 Million | -429.4 Million | -129.4 Million | 726.3 Million | -1.15 Billion |
Other working capital | -553.2 Million | 467 Million | 603.9 Million | 59.1 Million | -332.5 Million | 1.11 Billion |
Cash at beginning of period | 660.9 Million | 644.7 Million | 886.8 Million | 304.1 Million | 473.8 Million | 326.9 Million |
Cash at end of period | 623.4 Million | 660.9 Million | 644.7 Million | 886.8 Million | 304.1 Million | 473.8 Million |
Capital Expenditure | -685.9 Million | -174.9 Million | -403.8 Million | -409.7 Million | -237.3 Million | -779.9 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -37.5 Million | 16.2 Million | -242.1 Million | 582.7 Million | -169.7 Million | 146.9 Million |
Free Cash Flow | 2.06 Billion | 895.9 Million | 1.38 Billion | 1.84 Billion | 1.57 Billion | 2.65 Billion |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 1.08 Billion | 3.17 Billion | 1.04 Billion | 1.07 Billion | 675.3 Million | 386.9 Million |
Depreciation & Amortization | - | 467 Million | - | 116.6 Million | 120.6 Million | 120.1 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | -760.9 Million | - | - | - | - |
Other non-cash items | -1.08 Billion | 1.01 Billion | -1.04 Billion | -1.07 Billion | -675.3 Million | -386.9 Million |
Investing Cash Flow | - | -700.6 Million | - | - | - | - |
Investments in PPE | - | -685.9 Million | - | - | - | - |
Acquisitions | - | 1.2 Million | - | - | - | - |
Investment purchases | - | -15.9 Million | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | 7.2 Million | - | - | - | - |
Financing Cash Flow | - | -2.16 Billion | - | - | - | - |
Debt repayment | - | -2.15 Billion | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -781 Million | - | - | - | - |
Accounts receivables | - | -244.5 Million | - | - | - | - |
Accounts payables | - | 507.2 Million | - | - | - | - |
Inventory | - | -470.4 Million | - | - | - | - |
Other working capital | - | -553.2 Million | - | - | - | - |
Cash at beginning of period | - | 660.9 Million | - | 320 Million | -355.3 Million | 660.9 Million |
Cash at end of period | - | 623.4 Million | - | 1.07 Billion | 320 Million | 386.9 Million |
Capital Expenditure | - | -685.9 Million | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | -37.5 Million | - | 750.8 Million | 675.3 Million | -274 Million |
Free Cash Flow | - | 2.06 Billion | - | 1.07 Billion | 675.3 Million | 386.9 Million |
GLOBALVECT
BALRAMCHIN
TECHNVISN
1914
6157
CHEMTECH